Speaker illustration

Doctor Noemi Pavo

Medical University of Vienna, Vienna (Austria)

Member of:

European Society of Cardiology
Heart Failure Association

18F-FDG perfusion-metabolism mismatch 3 days after acute myocardial infarction predicts worse outcome: molecular glucose steel phenomenon visualized by hybrid PET-MRI images

Event: ESC Congress 2019

Topic: Hybrid and Fusion Imaging

Session: Nuclear cardiology: from bench to bedside

Thumbnail

The myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart

Event: ESC Congress 2019

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Treatment of heart failure

Thumbnail

Heart failure with reduced ejection fraction is characterized by systemic NEP downregulation

Event: Heart Failure 2019

Topic: Experimental Heart Failure

Session: Basic Science and Translational

Thumbnail

Role of neprilysin in myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart

Event: Heart Failure 2019

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Rapid Fire 2 - Biomarker: present and future

Thumbnail

Therapeutic response of peritoneal dialysis as a therapy for refractory heart failure and congestive right ventricular dysfunction

Event: Heart Failure 2018

Topic: Treatment, Other

Session: Chronic Heart Failure – Treatment

Thumbnail

Circulating Neprilysin is not a prognostic biomarker for cancer patients

Event: Heart Failure 2018

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

Extreme RAS regulation in HFrEF already on optimal treatment: the low and high renin phenotype heart failure

Event: ESC Congress 2017

Topic: Pharmacologic therapy

Session: Chronic heart failure (CHF)

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb